Related Experiment Video
Updated: Jul 30, 2025

08:52
Software-Assisted Quantitative Measurement of Osteoarthritic Subchondral Bone Thickness
Published on: March 18, 2022
3.0K
FoxO1/NLRP3 Inflammasome Promotes Age-Related Alveolar Bone Resorption.
1State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu, China.
Journal of Dental Research
|May 19, 2023
Summary
Forkhead transcription factor O1 (FoxO1) deficiency halts age-related alveolar bone loss by enhancing osteoblast differentiation. This suggests FoxO1 plays a key role in periodontitis and offers a potential therapeutic target.
Area of Science:
- Oral biology
- Gerontology
- Molecular biology
Background:
- Periodontitis is a common chronic oral disease exacerbated by aging.
- Aging involves chronic inflammation and contributes to alveolar bone loss.
- Forkhead transcription factor O1 (FoxO1) is crucial in cellular processes but its role in age-related bone loss is unknown.
Purpose of the Study:
- To investigate the role of FoxO1 in age-related alveolar bone resorption.
- To explore the therapeutic potential of targeting FoxO1 in periodontitis.
Main Methods:
- Generated osteoblast-specific FoxO1 knockout mice.
- Assessed alveolar bone loss and osteogenic potential in aged mice.
- Investigated the NLRP3 inflammasome pathway and reactive oxygen species (ROS) in osteoblasts.
Main Results:
- FoxO1 deficiency ameliorated age-related alveolar bone loss in mice.
- Osteogenic potential was enhanced in FoxO1-deficient osteoblasts.
- FoxO1 deficiency enhanced NLRP3 inflammasome signaling under oxidative stress.
Conclusions:
- FoxO1 plays a detrimental role in age-related alveolar bone resorption.
- Targeting FoxO1 may offer a novel therapeutic strategy for periodontitis.
- The NLRP3 inflammasome pathway is implicated in FoxO1-mediated bone loss.
Related Concept Videos
Osteoclasts in Bone Remodeling
3.1K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.1K
Bone Disorders
3.7K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
3.7K
Bone Remodeling
38.4K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
38.4K

